Literature DB >> 28402768

Primary Hyperoxaluria.

Dapeng Jiang1, Hongquan Geng2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28402768     DOI: 10.1056/NEJMicm1609986

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.

Authors:  Xiaoliang Fang; Lei He; Guofeng Xu; Houwei Lin; Maosheng Xu; Hongquan Geng
Journal:  Pediatr Nephrol       Date:  2019-05-23       Impact factor: 3.714

2.  The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants.

Authors:  Marie-Noëlle Méaux; Anne-Laure Sellier-Leclerc; Cécile Acquaviva-Bourdain; Jérôme Harambat; Lise Allard; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2022-01-11       Impact factor: 3.714

3.  Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1.

Authors:  Rui Zheng; Xiaoliang Fang; Xi Chen; Yunteng Huang; Guofeng Xu; Lei He; Yueyan Li; Xuran Niu; Lei Yang; Liren Wang; Dali Li; Hongquan Geng
Journal:  Clin Transl Med       Date:  2020-12

Review 4.  Primary hyperoxaluria diagnosed after kidney transplantation: a case report and literature review.

Authors:  Zhitao Cai; Mao Ding; Rengui Chen; Jiefu Zhu; Lian Li; Xiongfei Wu
Journal:  BMC Nephrol       Date:  2021-11-27       Impact factor: 2.388

5.  Integration of exome sequencing and metabolic evaluation for the diagnosis of children with urolithiasis.

Authors:  Yining Zhao; Xiaoliang Fang; Yanjie Fan; Yu Sun; Lei He; Maosheng Xu; Guofeng Xu; Yufeng Li; Yunteng Huang; Yongguo Yu; Hongquan Geng
Journal:  World J Urol       Date:  2020-09-16       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.